We recently discovered that LOX was involved in anaplastic thyroid cancer (ATC) progression and metastasis, and higher expression of LOX was associated with lower survival rates in patients with differentiated thyroid cancer [11]. Here, LOX is linked to thyroid gland undifferentiated (anaplastic) carcinoma.